Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Capricor Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 37 | 56 | +19 |
| Shares | 4.02M | 4.82M | +799.7K (+19.9%) |
| Value | $19.7M | $32.7M | +$13.1M (+66.4%) |
New holders (24)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (5)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 32,970 | $161.0K |
| Dimensional Fund Advisors LP | 14,839 | $72.6K |
| Group One Trading, L.P. | 2,006 | $9.81K |
| McGlone Suttner Wealth Management, Inc. | 423 | $2.07K |
| New Millennium Group LLC | 59 | $289 |